The inhibitory effect of delphinidin was maintained even when these cells were challenged with their ligand, EGF, indicating that delphinidin strongly inhibited EGFR signaling in NSCLC cells (Figure 1A). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.